By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endo Pharmaceuticals 

100 Endo Boulevard

Chadds Ford  Pennsylvania  19317  U.S.A.
Phone: 610-558-9800 Fax: 610-558-8979



Company News
Endo Pharmaceuticals (ENDP) And BioDelivery Sciences International (BDSI) Announce NDA Submission For Buprenorphine Hcl Buccal Film For The Management Of Moderate To Severe Chronic Pain 12/24/2014 7:19:13 AM
Endo Pharmaceuticals (ENDP) Completes Acquisition Of Rights To Natesto Testosterone Nasal Gel 12/9/2014 7:39:08 AM
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014 6:55:46 AM
Endo Pharmaceuticals (ENDP) Receives Final Approval For Generic Version Of Valcyte┬« 11/10/2014 9:01:28 AM
Endo Pharmaceuticals (ENDP) Reports Third Quarter Financial Results 11/5/2014 8:28:21 AM
Endo Pharmaceuticals (ENDP) To Announce Third Quarter 2014 Financial Results On November 5, 2014 10/21/2014 8:29:19 AM
Auxilium Pharmaceuticals (AUXL) Institutes "Poison Pill" To Fend Off $2.2B Endo Pharmaceuticals (ENDP) Offer 9/17/2014 6:16:56 AM
Endo Pharmaceuticals (ENDP) To Present At Morgan Stanley Global Healthcare Conference 2014 9/8/2014 10:36:03 AM
Endo Boss Confident That New U.S. Rules Will Not Force Drugmaker Back Into America's Tax Regime 8/11/2014 6:38:30 AM
Endo Pharmaceuticals (ENDP) Reports Second Quarter Financial Results 7/31/2014 9:25:47 AM